Published in Front Biosci on January 01, 2007
Prenatal stress and developmental programming of human health and disease risk: concepts and integration of empirical findings. Curr Opin Endocrinol Diabetes Obes (2010) 2.15
Risk of postpartum depressive symptoms with elevated corticotropin-releasing hormone in human pregnancy. Arch Gen Psychiatry (2009) 1.41
Continuous expression of corticotropin-releasing factor in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axes. Mol Psychiatry (2008) 1.18
Fetal programming of body composition, obesity, and metabolic function: the role of intrauterine stress and stress biology. J Nutr Metab (2012) 1.07
Placental Corticotropin-Releasing Hormone Mediates the Association Between Prenatal Social Support and Postpartum Depression. Clin Psychol Sci (2013) 0.89
Variation in the maternal corticotrophin releasing hormone-binding protein (CRH-BP) gene and birth weight in Blacks, Hispanics and Whites. PLoS One (2012) 0.78
Assessing the neuroendocrine stress response in the functional neuroimaging context. Neuroimage (2009) 0.76
Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. N Engl J Med (2014) 4.00
Inflammation and pregnancy. Reprod Sci (2009) 3.33
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril (2011) 2.80
Transvaginal ultrasonography in women receiving emergency contraception. Fertil Steril (2003) 2.00
miR-15a and miR-16-1 down-regulation in pituitary adenomas. J Cell Physiol (2005) 1.93
Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol (2008) 1.65
RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease. Surgery (2002) 1.49
Factor II: C activity and uterine artery Doppler evaluation to improve the early prediction of pre-eclampsia on women with gestational hypertension. J Hypertens (2005) 1.49
Differentiated thyroid cancers 11-20 mm in diameter have clinical and histopathologic characteristics suggesting higher aggressiveness than those < or =10 mm. Thyroid (2008) 1.47
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region. Endocrine (2015) 1.45
Amniotic fluid urocortin, CRF, oestriol, dehydroepiandrosterone sulfate and cortisol concentrations at mid-trimester: putative relationship with preterm delivery. Eur J Obstet Gynecol Reprod Biol (2009) 1.40
Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma. Thyroid (2005) 1.39
Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J Cell Physiol (2007) 1.37
A randomized controlled study comparing harmonic versus electrosurgery in laparoscopic myomectomy. Fertil Steril (2009) 1.19
Predictive value of circulating insulin-like growth factor I levels in ischemic stroke outcome. J Clin Endocrinol Metab (2006) 1.15
Single serum activin a testing to predict ectopic pregnancy. J Clin Endocrinol Metab (2007) 1.15
Endothelial cell adhesion to the extracellular matrix induces c-Src-dependent VEGFR-3 phosphorylation without the activation of the receptor intrinsic kinase activity. Circ Res (2010) 1.14
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies. Eur J Endocrinol (2009) 1.13
Endometrial expression and secretion of activin A, but not follistatin, increase in the secretory phase of the menstrual cycle. J Soc Gynecol Investig (2003) 1.12
Uterine leiomyoma: available medical treatments and new possible therapeutic options. J Clin Endocrinol Metab (2013) 1.12
Occurrence of pituitary dysfunction following traumatic brain injury. J Neurotrauma (2004) 1.10
Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications. Hum Reprod Update (2011) 1.10
Hypopituitarism after traumatic brain injury. Eur J Endocrinol (2005) 1.08
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study. Endocr Relat Cancer (2007) 1.07
Defining future directions for endometriosis research: workshop report from the 2011 World Congress of Endometriosis In Montpellier, France. Reprod Sci (2013) 1.06
Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto's thyroiditis. PLoS Pathog (2012) 1.06
Insulin-lowering agents in the management of polycystic ovary syndrome. Endocr Rev (2003) 1.05
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. Eur J Endocrinol (2010) 1.04
Insulin-dependent diabetes in men is associated with hypothalamo-pituitary derangement and with impairment in semen quality. Hum Reprod (2002) 1.03
Serum and tissue expression of activin a in postmenopausal women with breast cancer. J Clin Endocrinol Metab (2002) 1.02
Prenatal diagnosis and multidisciplinary approach to the congenital gingival granular cell tumor. J Pediatr Surg (2006) 1.01
Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study. J Clin Endocrinol Metab (2012) 1.01
Anterior pituitary function may predict functional and cognitive outcome in patients with traumatic brain injury undergoing rehabilitation. J Neurotrauma (2007) 1.00
Impaired placental nutrient transport in mice generated by in vitro fertilization. Endocrinology (2012) 0.98
Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma. Thyroid (2005) 0.97
Urinary S100B protein concentrations are increased in intrauterine growth-retarded newborns. Pediatrics (2006) 0.97
High prevalence of differentiated thyroid carcinoma in acromegaly. Clin Endocrinol (Oxf) (2005) 0.97
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids. Endocr Relat Cancer (2010) 0.97
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism. J Clin Endocrinol Metab (2005) 0.96
Understanding spontaneous preterm birth: from underlying mechanisms to predictive and preventive interventions. Reprod Sci (2013) 0.96
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients. Endocr Relat Cancer (2012) 0.96
Complex networks of multiple factors in the pathogenesis of uterine leiomyoma. Fertil Steril (2013) 0.95
Surgical scar endometriosis after Cesarean section: a case report. Gynecol Endocrinol (2006) 0.95
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone. Neuroendocrinology (2003) 0.94
Isoprostanes in amniotic fluid: a predictive marker for fetal growth restriction in pregnancy. Free Radic Biol Med (2005) 0.94
Regression of liver metastases of occult carcinoid tumor with slow release lanreotide therapy. World J Gastroenterol (2005) 0.94
Angiogenesis and endometriosis. Obstet Gynecol Int (2013) 0.93
Electro-cautery of myomas during caesarean section--two case reports. Eur J Obstet Gynecol Reprod Biol (2002) 0.93
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization. Hum Mutat (2010) 0.93
Urocortin increases IL-4 and IL-10 secretion and reverses LPS-induced TNF-alpha release from human trophoblast primary cells. Am J Reprod Immunol (2009) 0.92
Endometriosis in Italy: from cost estimates to new medical treatment. Gynecol Endocrinol (2009) 0.92
Activins and related proteins in the establishment of pregnancy. Reprod Sci (2010) 0.92
Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis. Hum Reprod Update (2013) 0.91
Maternal risk factors for preterm birth: a country-based population analysis. Eur J Obstet Gynecol Reprod Biol (2011) 0.91
mTOR, p70S6K, AKT, and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids. Endocr Relat Cancer (2013) 0.91
Listeriosis in pregnancy: a case report. J Matern Fetal Neonatal Med (2005) 0.91
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion. Endocr Relat Cancer (2007) 0.91
Somatostatin receptor subtype 1 selective activation in human growth hormone (GH)- and prolactin (PRL)-secreting pituitary adenomas: effects on cell viability, GH, and PRL secretion. J Clin Endocrinol Metab (2003) 0.90
Predictive value of hormone measurements in maternal and fetal complications of pregnancy. Endocr Rev (2002) 0.89
Small thymus at birth: a predictive radiographic sign of bronchopulmonary dysplasia. Pediatrics (2002) 0.89
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression. Endocr Relat Cancer (2007) 0.89
Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome. Fertil Steril (2007) 0.88
Neuroendocrine aspects of placenta and pregnancy. Gynecol Endocrinol (2012) 0.88
The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis. Eur J Obstet Gynecol Reprod Biol (2004) 0.88
Levels of p27 sensitize to dual PI3K/mTOR inhibition. Mol Cancer Ther (2011) 0.88
Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimen. Contraception (2009) 0.88
miR-26a plays an important role in cell cycle regulation in ACTH-secreting pituitary adenomas by modulating protein kinase Cδ. Endocrinology (2013) 0.88
Conventional and Nuclear Medicine Imaging in Ectopic Cushing's Syndrome: A Systematic Review. J Clin Endocrinol Metab (2015) 0.88
Differential expression of follistatin and FLRG in human breast proliferative disorders. BMC Cancer (2009) 0.87
New trends for the medical treatment of endometriosis. Expert Opin Investig Drugs (2012) 0.87
Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction. Obstet Gynecol Int (2013) 0.87
Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer. Thyroid (2014) 0.87
The link between endometriosis and ovarian cancer: clinical implications. Int J Gynecol Cancer (2014) 0.87
Histologic chorioamnionitis at term: implications for the progress of labor and neonatal wellbeing. J Matern Fetal Neonatal Med (2012) 0.87
Urocortins in human reproduction. Peptides (2004) 0.87
Runx2 mRNA expression in the tissue, serum, and circulating non-hematopoietic cells of patients with thyroid cancer. J Clin Endocrinol Metab (2012) 0.87
Inhibins in female and male reproductive physiology: role in gametogenesis, conception, implantation and early pregnancy. Hum Reprod Update (2004) 0.87
Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome. Fertil Steril (2002) 0.87
Molecular basis of pharmacological therapy in Cushing's disease. Endocrine (2013) 0.86
Small thymus at birth and gestational age. Eur J Pediatr (2002) 0.86
Women with endometriosis at first pregnancy have an increased risk of adverse obstetric outcome. J Matern Fetal Neonatal Med (2014) 0.86
Activin betaA subunit, follistatin and follistatin-like 3 are expressed in the endometrium of ovariectomized rats and regulated by estrogen replacement. J Mol Histol (2008) 0.86